In episode 7, hosts Sarah Murphy and David Willows discuss David’s first attempt to record an interview without Sarah in the studio (1:13). David then introduces podcast guests Ned Pojskic, GSC’s Leader, Pharmacy and Health Provider Relations, and Cheryl Koehn, the Founder and President of patient organization Arthritis Consumer Experts (4:05). David asks Ned to describe Canada’s progress with biosimilar adoption (spoiler alert – it is poor) and what public/private payors are (not) doing to support their introduction into the Canadian health care environment (6:30). Next, Cheryl explains the perspective of a patient organization that supports the adoption of biosimilars (13:55), and discusses the challenges of moving the physician community to new approaches in an environment where originator biologics manufacturers have systemic advantages in reaching physicians/patients (21:30). Ned and Cheryl address the “fear-mongering” that still happens on this topic (25:18), and David ends the discussion by asking whether they are concerned or optimistic about the future of biosimilar adoption in Canada (29:54).